Ticker
SGMOCompany Name
SANGAMO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -31.98% | $ 145.73M | $ 46.61M |
3/31/2025 | -9.83% | $ 174.18M | $ 17.12M |
12/31/2024 | -12.9% | $ 226.96M | $ 29.28M |
9/30/2024 | -3.94% | $ 565.43M | $ 22.29M |
6/30/2024 | -10.81% | $ 206.14M | $ 22.29M |
3/31/2024 | -27.14% | $ 108.53M | $ 29.45M |
12/31/2023 | -11.42% | $ 140.44M | $ 16.04M |
9/30/2023 | -33.87% | $ 104.81M | $ 35.5M |
6/30/2023 | -39.35% | $ 201.91M | $ 79.45M |
3/31/2023 | -43.9% | $ 218.22M | $ 95.8M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for SANGAMO THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 148.01M ]) / Market Cap [ $ 1.67B ]
(=) Buyback Yield [ -8.85% ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.7% |